Yao Lu

Yao Lu

Auto-generated profile, based on publicly available information

Yao Lu

Guangdong Provincial Key Laboratory of Advanced Biomaterials, Department of Biomedical Engineering, Southern University of Science and Technology, Shenzhen, Guangdong 518055, P. R. China

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 October 2026 in Journal of Innovative Optical Health Sciences
Verified
Journal Article
Open access
ZWZhuli Wu
Zhuli Wu
MGMingyue Gong
Mingyue Gong
YLYao Lu
Yao Lu
XFXiaofeng Fang
Xiaofeng Fang
YKYan Kuang
Yan Kuang
CWChangfeng Wu
Changfeng Wu
Precise quantification of tissue oxygenation (pO[Formula: see text] is important for understanding tumor progression and evaluating metabolic therapies. However, conventional intensity-based optical oxygen sensors suffer from severe signal fluctuations for in vivo measurements due to tissue scattering and excitation conditions. Here, we present a robust quantitative oxygen sensing platform by using ultra-bright phosphorescent semiconducting polymer dots (Pdots) and a custom-built time-gated phosphorescence lifetime imaging (PLIM) system. Polyfluorene serves as a light-harvesting unit that sensitizes oxygen-responsive metalloporphyrin moieties through intraparticle energy transfer, yielding bright oxygen-sensitive Pdots with a large excitation–emission separation. The PLIM system consists of an intensified scientific complementary metal–oxide–semiconductor (sCMOS) camera with an internal trigger for pulsed LED excitation. We demonstrated the longitudinal imaging of local microenvironmental pO 2 in a murine breast tumor model over an 8-day period. While intensity imaging suffers from signal degradation due to tumor growth and probe dilution, the PLIM system reliably captures a dynamic change in tumor oxygenation, with pO 2 increasing from a hypoxic level (<10[Formula: see text]mmHg) on Day 1 to ∼43[Formula: see text]mmHg on Day 8. This trend likely reflects tumor vascular remodeling during early-stage growth. Our study provides a promising tool for tracking subcutaneous tissue metabolic dynamics and evaluating hypoxia-targeted cancer therapies.